Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

September 29, 2019

  PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 29 September 2019 – Agendia, Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at the European Society for Medical Oncology (ESMO) Congress 2019, taking place from September 27 to October 1 in Barcelona, Spain.…

Read more

Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology

June 20, 2019

  PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 20 June 2019 – Agendia, Inc., a world leader in precision oncology, announced today the open access publication of MammaPrint and BluePrint Molecular Diagnostics using targeted RNA Next-Generation Sequencing technology in the Journal of Molecular Diagnostics. The publication summarized the analytical and clinical validation studies…

Read more

BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes

June 3, 2019

PRESS RELEASE New data presented at ASCO underscores importance of genomic profiling for African-American women with breast cancer whose unique tumor biology can sometimes lead to poorer prognoses   IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 1 June 2019 – Agendia, Inc., a world leader in precision oncology, today announced the presentation of study results…

Read more

Agendia Appoints Two Industry Veterans to Board of Directors

May 31, 2019

PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 31 May 2019 – Agendia, Inc., a world leader in precision oncology, announced today the appointment of industry veterans Laurie Heilmann and François Ferré, Ph.D. to its board of directors. With more than 30 years of executive leadership experience, Laurie Heilmann is the former president of…

Read more